CureVac NV, a clinical-stage biopharmaceutical company, is focused on developing various transformative drugs based on messenger ribonucleic acid (mRNA). The company is headquartered in Tbingen, Germany. Show more

FRIEDRICH-MIESCHER-STRASSE 15, TÜBINGEN, GERMANY, 72076, Tübingen, 72076, USA

BIOTECHNOLOGY
HEALTHCARE

Market Cap

1.049B

52 Wk Range

$4.00 - $5.55

Previous Close

$4.66

Open

$4.66

Volume

N/A

Day Range

$4.66 - $4.66

Enterprise Value

599.3M

Cash

416.1M

Avg Qtr Burn

N/A

Insider Ownership

0.10%

Institutional Own.

10.43%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.